Greece Vaccine Industry Outlook 2024 - 2028

See how Greece Vaccine performed compared to key markets.

Key Market Indicators

**Greek Vaccination Coverage Reaches Near-Universal Levels** ATHENS – Greece is on track to maintain its near-universal vaccination coverage for children aged one year old, with projections showing a steady rate of 99% through to 2028. This figure has remained unchanged since 2005, indicating a consistent commitment to childhood immunization. In 2023, the vaccination coverage for one-year-olds was close to 100%, marking a slight increase from 99% in 2022. This represents a one-point rise from the previous year. Historical data since 1985 reveal a modest but steady increase in vaccination rates, with an average annual growth of 0.2 percentage points. **Vaccine Imports and Exports on the Rise** On the economic front, Greece’s vaccine imports are projected to reach approximately $155 million by 2028, up from $135 million in 2023. This reflects a compound annual growth rate (CAGR) of 2% over the period. Since 1993, the demand for vaccines in Greece has grown by an average of 4% annually. Simultaneously, Greek vaccine exports are expected to hit around $3.4 million by 2028, rising from $3.2 million in 2023. This growth rate averages 1% per year. Since 1998, the supply of vaccines from Greece has increased at an annual rate of 2.4%. In 2023, Greece ranked 37th in global vaccine exports, with South Africa marginally ahead at the same level of $3.2 million. Leading the rankings were Belgium, the United Kingdom, and France, occupying the second, third, and fourth spots respectively.

Greece Vaccine Market Data and Forecasts

How much will Greece Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to Greece
Forecast: Export of Vaccines for Human Use from Greece

Other Top Countries about Vaccine